咪康唑结构式
|
常用名 | 咪康唑 | 英文名 | Miconazole |
|---|---|---|---|---|
| CAS号 | 22916-47-8 | 分子量 | 416.129 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 555.1±50.0 °C at 760 mmHg | |
| 分子式 | C18H14Cl4N2O | 熔点 | 159-163ºC | |
| MSDS | N/A | 闪点 | 289.5±30.1 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
咪康唑用途属咪唑类广谱抗霉菌药。对新生隐球菌、念珠菌、球孢子菌、组织胞浆菌和皮炎牙生菌等抗菌活性好。对毛发癣菌和皮肤癣菌有效,但对由霉菌和部分白色含球菌作用差。 |
| 中文名 | 咪康唑 |
|---|---|
| 英文名 | Miconazole |
| 中文别名 | 1-[2-(2,4-二氯苯基)-2-[(2,4-二氯苯基)甲氧基]乙基]-1H-咪唑 | 霉可唑 |
| 英文别名 | 更多 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 555.1±50.0 °C at 760 mmHg |
| 熔点 | 159-163ºC |
| 分子式 | C18H14Cl4N2O |
| 分子量 | 416.129 |
| 闪点 | 289.5±30.1 °C |
| 精确质量 | 413.986023 |
| PSA | 27.05000 |
| LogP | 5.93 |
| InChIKey | BYBLEWFAAKGYCD-UHFFFAOYSA-N |
| SMILES | Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 |
| 外观性状 | 白色粉末 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.625 |
|
~70%
咪康唑 22916-47-8 |
| 文献:Cruz-Almanza, Raymundo; Hernandez, Teresa; Perez, Francisco; Lemini, Cristina Organic Preparations and Procedures International, 1992 , vol. 24, # 3 p. 342 - 345 |
|
~%
咪康唑 22916-47-8 |
| 文献:Organic Preparations and Procedures International, , vol. 24, # 3 p. 342 - 345 |
|
~%
咪康唑 22916-47-8 |
| 文献:Organic Preparations and Procedures International, , vol. 24, # 3 p. 342 - 345 |
| 海关编码 | 2933290090 |
|---|---|
| 中文概述 | 2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection.
Acta Clin. Belg. 69(1) , 53-61, (2014) Azole antifungals are a group of fungistatic agents that can be administered orally or parenterally. The determination of the concentrations of these antifungals (miconazole, fluconazole, ketoconazole... |
|
|
A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.
Eur. J. Drug Metab. Pharmacokinet. 39(4) , 263-76, (2014) The purpose of this study was to evaluate the impact of structural modifications on the 15-membered macrolactone ring and/or substituents on the in vitro ADME properties and in vivo pharmacokinetic (P... |
|
|
HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin.
J. Chromatogr. Sci. 50(10) , 855-61, (2012) High-performance liquid chromatography (HPLC) and chemometric methods were applied to the simultaneous determination of the two nonsteroidal antifungal drugs, miconazole (MIC) and nystatin (NYS). The ... |
| 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole |
| EINECS 245-324-5 |
| 1-[2,4-Dichloro-b-[(2,4-dichlorobenzyl)oxy]phenethyl]imidazole |
| Daktarin IV |
| MFCD00216019 |
| MONISTAT IV |
| Minostate |
| 1-(2,4-dichloro-β-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole |
| 1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- |
| Desenex |
| Miconozole |
| (±)-Miconazole |
| Monistat |
| mjr1762 |
| 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole |
| 1-{2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole |
| micronazol |
| 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- |
| Miconazole |
| Zeasorb-AF |